MSB 3.21% $1.13 mesoblast limited

Will the FDA refuse approval in the face of the favourable ODAC 9 versus 1 vote?, page-28

  1. 100 Posts.
    lightbulb Created with Sketch. 65
    I think the M&G selling has put so much downward pressure on the price that it’s offset the gains we otherwise would have seen. I believe the market is expecting approval and priced this in after the 9-1 vote.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.